Picosecond pulse duration laser treatment for dermal melanocytosis in Asians : A retrospective review.

Picosecond pulse duration laser treatment for dermal melanocytosis in Asians : A retrospective review.
复制标题

皮秒脉冲持续激光治疗亚洲人真皮黑素细胞增多症:回顾性评论。

DOI:
10.5978/islsm.16-or-07
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
K. Kishi
K. Kishi
中科院分区:
--
文献类型:
--
作者:
T. Ohshiro;T. Ohshiro;K. Sasaki;K. Kishi

文献摘要

被引文献

相似文献

背景与目的:近年来,新型皮秒持续激光(ps-激光器)已被开发用于治疗多色和顽固性纹身,其安全性和有效性已得到报道。因此,我们假设ps激光可能是皮肤色素病变的一种替代治疗方法,并进行了回顾性评价ps激光的有效性和安全性。对象和方法:对10例皮肤色素病变患者(年龄4个月~ 52岁)进行回顾性摄影复习,其中太田痣6例,异位蒙古斑3例,蒙古斑1例。2014年4月至2015年12月,患者在Ohshiro诊所接受皮秒755 nm亚历山大激光(ps-Alex激光)和皮秒1064 nm Nd:YAG激光(ps-Nd:YAG激光)治疗(ps-Alex激光,7例;ps-Nd:YAG激光,3例,1 ~ 3次治疗)。改善以色素沉着清除率的百分比进行评估,将基线结果与最终治疗后3个月的结果进行比较,使用5类分级量表:差,0-24%;公平的,25 - 49%;好,50 - 74%;好,75 - 94%;完成,95-100%的改进。对不良事件也进行了评估。结果:10例患者均获得一般到优异的临床改善。ps-Alex激光治疗引起短暂性色素沉着,随后在3个月的随访中改善至完全消退。ps-Nd:YAG激光引起严重的短暂性红斑和肿胀,但没有炎症后色素沉着。结论:我们的研究结果表明,755 nm和1064 nm的ps激光治疗皮肤色素病变是有效的,并且不良事件最小。
Background and aims: Recently novel picosecond duration lasers (ps-lasers) have been developed for the treatment of multicolored and recalcitrant tattoos, and safety and efficacy have been reported. We therefore hypothesized that the ps-laser could be an alternative treatment for dermal pigmented lesions and performed a retrospective review to evaluate the efficacy and safety of the ps-laser. Subjects and methods: A retrospective photographic review of 10 patients with dermal pigmented lesions was performed (ages from 4 months to 52 yr), 6 nevus of Ota, 3 ectopic Mongolian spots and 1 Mongolian spots. The patients were treated in the Ohshiro Clinic with picosecond 755 nm alexandrite laser (ps-Alex laser) and picosecond 1064 nm Nd:YAG laser (ps-Nd:YAG laser) from April 2014 to December 2015 (ps-Alex laser, 7 patients; ps-Nd:YAG laser, 3 patients, 1 to 3 treatment sessions). Improvement was evaluated as percentage of pigmentation clearance comparing the baseline findings with those at 3 months after the final treatment using a five category grading scale: Poor, 0-24%; Fair, 25-49%; Good, 50-74%; Excellent, 75-94%; and Complete, 95-100% improvement. Adverse events were also assessed. Results: All ten patients obtained clinical improvement ranging from fair to excellent. Treatment with the ps-Alex laser caused transient hyperpigmentation followed by improvement to complete resolution at 3 months follow-up. The ps-Nd:YAG laser caused severe transient erythema and swelling but no post-inflammatory hyperpigmentation. Conclusions: Our results suggest that the 755 nm and 1064 nm ps-lasers are efficacious for the treatment of dermal pigment lesions, with minimum adverse events.